These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7160202)

  • 21. Osteoporosis associated with the treatment of paraphilias: a clinical review of seven case reports.
    Grasswick LJ; Bradford JM
    J Forensic Sci; 2003 Jul; 48(4):849-55. PubMed ID: 12877306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiandrogenic treatment in a university setting.
    Young CR
    J Am Coll Health; 1987 May; 35(6):277-8. PubMed ID: 3584712
    [No Abstract]   [Full Text] [Related]  

  • 23. Low-dose oral medroxyprogesterone acetate in the management of the paraphilias.
    Gottesman HG; Schubert DS
    J Clin Psychiatry; 1993 May; 54(5):182-8. PubMed ID: 8509348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of paraphilia in young adults with leuprolide acetate: a preliminary case report series.
    Saleh FM; Niel T; Fishman MJ
    J Forensic Sci; 2004 Nov; 49(6):1343-8. PubMed ID: 15568711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medroxyprogesterone treatment for paraphiliacs.
    Kravitz HM; Haywood TW; Kelly J; Wahlstrom C; Liles S; Cavanaugh JL
    Bull Am Acad Psychiatry Law; 1995; 23(1):19-33. PubMed ID: 7599368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical castration: MPA treatment of the sexual offender.
    Fitzgerald EA
    Am J Crim Law; 1990; 18(1):1-60. PubMed ID: 15991431
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative use of 2 preparations of Depo Provera with semestral duration of action].
    Brat T
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):338-40. PubMed ID: 4681540
    [No Abstract]   [Full Text] [Related]  

  • 28. [On the use of the testosterone blocking agent cyproterone acetate (SH 714) in hospitalized sex offenders and psychiatric patients. (Preliminary report)].
    Hoffet H
    Praxis; 1968 Feb; 57(7):221-30. PubMed ID: 5695087
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antiandrogenic treatment of 2 psychiatric patients].
    Halvorsen KA; Kobbernagel F; Kaldan B
    Ugeskr Laeger; 1972 Oct; 134(42):2206-7. PubMed ID: 5082377
    [No Abstract]   [Full Text] [Related]  

  • 30. Hormonal contraception: is it worth it?
    Hellier S
    Nurse Pract; 2008 Oct; 33(10):37-9. PubMed ID: 18953241
    [No Abstract]   [Full Text] [Related]  

  • 31. Psychosocial and biological treatment considerations for the paraphilic and nonparaphilic sex offender.
    Saleh FM; Guidry LL
    J Am Acad Psychiatry Law; 2003; 31(4):486-93. PubMed ID: 14974804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimizing antilibidinal treatment with medroxyprogesterone acetate.
    Stewart JT
    J Am Geriatr Soc; 2005 Feb; 53(2):359-60. PubMed ID: 15673373
    [No Abstract]   [Full Text] [Related]  

  • 33. [Castration of prostate cancer patients and cognition].
    Portin R; Koskinen A; Helenius H; Nurmi M; Salminen E
    Duodecim; 2005; 121(16):1784-5. PubMed ID: 16268226
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyproteronacetate in sexualogical outpatient practice.
    Boas Cv
    Psychiatr Neurol Neurochir; 1973; 76(2):151-4. PubMed ID: 4700933
    [No Abstract]   [Full Text] [Related]  

  • 35. [Sex deviations and their chemical treatment].
    Delaloye R
    Rev Med Suisse Romande; 1974 Jul; 94(7):565-73. PubMed ID: 4842197
    [No Abstract]   [Full Text] [Related]  

  • 36. Degarelix (firmagon) for prostate cancer.
    Med Lett Drugs Ther; 2009 Oct; 51(1323):82-3. PubMed ID: 19838145
    [No Abstract]   [Full Text] [Related]  

  • 37. Sexually aggressive men.
    Bradford JM; Bourget D
    Psychiatr J Univ Ott; 1987 Sep; 12(3):169-75. PubMed ID: 3313481
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antiandrogenic pharmacotherapy of sexual offenders and home leave steps in the forensic psychiatric hospital Berlin].
    Briken P; Welzel K; Habermann N; Hill A; Berner W
    Psychiatr Prax; 2009 Jul; 36(5):232-7. PubMed ID: 19437383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individual variations of serum testosterone in patients with prostate cancer receiving androgen deprivation therapy. Commentary.
    Koupparis A
    BJU Int; 2009 Jul; 104(1):124; author reply 124-5. PubMed ID: 19646128
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacological agents for treatment of paraphilias and hypersexual disorders].
    Hebebrand K; Hebebrand J; Remschmidt H
    Fortschr Neurol Psychiatr; 2002 Sep; 70(9):462-75. PubMed ID: 12215919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.